Skip to main content

Mass Tort Review

Mass Tort Review

Mass Tort Review

Introduction

Litigating an action such as the one involving Xarelto requires myriad factors to be in place. Neural IT has a great track record of producing quality work in both the Mass Tort & Personal Injury arenas.

In an instance such as a Xarelto litigation, Neural IT's highly trained medical doctors look through a patient's medical and pharmacy records that would indicate usage of Xarelto, duration of Xarelto intake, and complications and their treatment after Xarelto's intake.

Medical Record Review of a typical Xarelto case should take approximately 3 hours in most instances. This estimate may vary in cases based on the volume of medical and pharmacy records.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!